Omeprazol Medical Valley (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Medical Valley, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑oesophageal reflux disease and related conditions in adults. GNH USA supplies Omeprazol Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSA‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Acute interstitial nephritis: kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Fracture risk: possible reduction in bone mineral density with long‑term use. - Hepatotoxicity: elevated liver enzymes or hepatitis.

Before initiating therapy, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate for H. pylori infection: may require combination therapy. - Use the lowest effective dose: limit duration to the shortest period required. - Monitor for vitamin B12 deficiency: long‑term therapy can affect absorption. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atorvastatin: increased serum concentrations, heightened risk of myopathy. - Warfarin: potential increase in INR, requiring closer monitoring.

Moderate Interactions (Monitor Closely): - Digoxin: higher plasma levels may occur. - Methotrexate: reduced renal clearance can raise toxicity risk. - Ketoconazole: decreased absorption due to higher gastric pH. - Iron supplements: diminished uptake, consider spacing dosing times. - Phenytoin: altered metabolism may affect seizure control.